Evaluation of the clinical efficacy and safety of fluticasone propionate/ formoterol fumarate combination (FFC) for the treatment of bronchial asthma-with and without use of an inhalation device

Evaluation of the clinical efficacy and safety of fluticasone propionate/ formoterol fumarate combination (FFC) for the treatment of bronchial asthma-with and without use of an inhalation device - Evaluation of the clinical efficacy and safety of fluticasone propionate/ formoterol fumarate combination (FFC) for the treatment of bronchial asthma-with and without use of an inhalation device

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015602

Enrollment

Registered

2014-11-04

Start date

2014-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchial Asthma

Interventions

Inhalation of FFC without AeroChamber Plus--&gt

With AeroChamber Plus Inhalation of FFC with AeroChamber Plus--&gt

Without AeroChamber Plus

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Outpatient >=20 years old 2) Patients who were diagnosed with asthma and need ICS and LABA by the investigator. 3) Patients with %FEV1 more than 60% at visit1 4) Documented agreement with full explanation of the study to the participant.

Exclusion criteria

Exclusion criteria: 1) Patients with any serious cardiac, hepatic, renal, hematological disorder, or any other serious complication 2) Patients who have coexisting malignant tumor or a history of malignant tumor 3) Patients who have history of smoking within the past 1 year 4) Patients who are pregnant, lactating, possibly pregnant, or those who desire to become pregnant during their participation in the study 5) Others deemed unsuitable by the investigator

Design outcomes

Primary

Measure	Time frame
FEV1	—

Secondary

Measure	Time frame
Lung function Score Asthma Control Questionnaire FeNO Impulse Oscillation System	—

Countries

Japan

Contacts

Public ContactYuji Tohda

Kinki University Department of respiratory medicine and allergology

tohda@med.kindai.ac.jp072-366-0221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026